Medicare AdvantageCoverageMedium impact
MA11.052f, Ablation of Lung Tumors
Independence Blue Cross·Pulmonology, Oncology, Radiology +1 more·Medical Policy
Effective date
Jun 10, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.052f for lung tumor ablation procedures has been reissued and will take effect June 10, 2026. This is a policy update that may affect coverage criteria, billing requirements, or documentation standards for ablation procedures targeting lung tumors.
Action Required
Before June 10, 2026: Billing team should review the full updated policy MA11.052f for any changes to coverage criteria, prior authorization requirements, or documentation standards for lung tumor ablation procedures. Access the complete policy details at the source URL to identify specific billing or clinical documentation changes that may affect claim processing.